Post Covid: The Return of Covid By Michael Baxter -April

New Post Public Reply Private Reply Replies (1) Message Board
john1234 Bhawks #81017
358
Post Covid: The Return of Covid
By Michael Baxter -April 4, 2022

Even as the nation’s bluest states eased Covid-19 restrictions earlier this year, the U.S. architects of the plandemic huddled beneath the hum and flicker of fluorescent lights at the CDC’s Atlanta headquarters and groused about how elected officials were abandoning mask and vaccination mandates for fear of midterm defeat, a CDC whistleblower with access to a partial transcript of a 4 March meeting told Real Raw News.

The usual suspects were present: Deep State Dr. Anthony Fauci; CDC Director Rochelle Walensky; Secretary of Health and Human Services Xavier Becerra; Covid-19 Task Force members Drs. James Hildreth, Joneigh Khaldun, and Homer Venters; and, curiously, Moderna CEO Stéphane Bancel, a French citizen.

According to our source, a furious Bancel griped about the precipitous drop in vaccine sales, bemoaning America’s reluctance to accept frequent boosters and recurring mask mandates as part of the “new normal” way of life.

“Only 54% of this country is fully vaccinated, and less boosted. What is wrong here? Don’t your people know that people are dying left and right of Covid-19 and that without boosters more will die every single day. In other countries it’s not like this—they welcome vaccines and boosters,” Bancel reportedly said.

“We want mandates as much as you do,” said Rochelle Walensky, “but the triple vaccinated people are still getting sick, either from Covid or the vaccine, and I’m not saying its yours. I’m trying to choose my words carefully here. If U.S. citizens believe the vaccine doesn’t work, they will not take it.”

“Stéphane, everyone here wants Americans vaccinated, boosted, and hunkered down for the long haul. We have obstacles to overcome. We didn’t think Ukraine would be a roadblock,” Fauci said.

Fauci’s comment likely referred to the U.S. media’s instantaneous lack of Covid coverage that began when Russian President Vladimir Putin started his “Special Military Operation” in Ukraine. Covid headlines evaporated, replaced by spurious stories that impugned Putin’s character.

“Our friends in Europe and China will help force Covid back centerstage,” Xavier Becerra said. “And if it’s up to us, we won’t be waiting for midterm results to make it happen. We don’t share the same fears as our elected counterparts. Being appointed has its privileges.”

Moreover, our source said the insidious cabal spent hours discussing the fictitious BA.2 Subvariant and how China intended to use it to strengthen public fear of Covid-19 by once again locking down enormous segments of its population, a prediction that saw fruition weeks later, when Shanghai put 26 million people on indefinite house arrest.

“If China will make this happen, why can’t you do it here?” Bancel complained.

“In case you haven’t noticed, we aren’t China, at least not yet, and the citizens in the U.S are, unfortunately, more rebellious than the Chinese,” Becerra said.

Fauci, our source said, agreed that American health agencies had reached a nodus in their relationship with the American public.

“They’ve stopped trusting us,” Fauci admitted. “We must regain that trust.”

“And the best way to do that is scare people shitless,” Becerra said.


They unanimously agreed to use every means at their disposal to bring about a Covid resurgence well ahead of the 2022 midterms.

“There’s a big disharmony between elected and appointed officials. This could further unravel the fake pandemic, or it could reinvigorate Covid hysteria. I guess we’ll all find out soon,” our source said.

In closing, he mentioned that the purveyors of the plandemic had held numerous meetings with Big Pharma CEOs and described their relationship as “symbiotic.”

Correction: We mistakenly referred to the upcoming midterm elections as the 2020 midterms. We have corrected the mistake, with thanks to the reader who pointed it out in the comments.

RRN is an independent publisher that relies on reader support. We fight for truth and freedom of the press in an oppressed society. We use GiveSendGo, a Christian-based fundraising company, through which to collect donations. Please do not give your hard-earned money to sites or channels that copy/paste our intellectual property. We spend countless hours vetting, researching, and writing. Thank you. Every dollar helps.

source
https://realrawnews.com/2022/04/post-covid-th...-of-covid/
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Synagro Technologies Faces Lawsuit Over Unpaid Expenses

Updated Category News Views 6

Another Day, Another Lawsuit in Corporate America When it rains, it pours, especially in the corporate world where companies occasionally seem to forget they're playing with other people's livelihoods. Now, it's Synagro Technologies, Inc. facing the music. The company is under fire from Blumenthal Nordrehaug Bhowmik De Blouw LLP, a law firm well-versed in employee rights...

Continue Reading
Quay Shines in 2026 Prescription Sunglasses Lineup

Updated Category News Views 5

Spotlight on Quay: A Fashion-Forward Prescription Glasses that make you look good and actually correct your vision? That's the holy grail right there. Consumer365 just put Quay front and center in their 2026 rundown of the best prescription sunglasses out there. Let's break this down and see what's got folks buzzing. Diving into Style and Substance Now, if you're like me,...

Continue Reading
Revamping Children's Radiotherapy: Leo Cancer Care's Vision

Updated Category News Views 5

The latest buzz in pediatric radiotherapy is shaking things up, and it’s all thanks to a game-changing shift in how treatment is delivered to kids. We're eyeballing Leo Cancer Care's innovative approach that might just redefine how these young patients face their battles. Standing Tall: A New Chapter in Proton Therapy In June, Stanford Medicine dished out the first...

Continue Reading
AI Memory Growth Pushes Limits at GMIF2026 Summit

Updated Category News Views 4

The Memory and Storage Race in the AI Era The 5th GMIF2026 Innovation Summit wrapped up in Shenzhen, and boy, was it a heavyweight bout. You could practically feel the tension in the room as industry giants sparred over the future of memory and storage in AI. This wasn't just another trade show pow-wow; this was a strategic chess match over where AI infrastructure is...

Continue Reading
IASO's FUCASO Shows Robust Results in 2026 Study

Updated Category News Views 7

IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...

Continue Reading
Salveo Home Care Faces Class Action Over Labor Violations

Updated Category News Views 5

Another Company Lands in Hot Water Alright, it looks like Salveo Home Care is in the spotlight for all the wrong reasons. The home care provider—which should have been minding its P's and Q's—is now facing a class action suit. Why, you ask? Well, for allegedly skimping on wages and dodging legal obligations that leave their employees hanging dry. The Allegations are...

Continue Reading
DKS Facing Class Action Over Stock Slump Allegations

Updated Category News Views 3

A Burst Bubble at DICK'S Sporting Goods Grit your teeth and hang on—DICK'S Sporting Goods has stumbled, and investors are supposed to just weather the storm. From September 8, 2025, through August 24, 2026, if you held DICK'S shares, you've got some explaining to do, or at least you better start reading the fine print. Take note, folks: the deadline to file for lead...

Continue Reading
Fuse Oncology Showcases New iRT Workflow at ASTRO

Updated Category News Views 4

Revolutionizing Charge Capture in Oncology Fuse Oncology's latest showcase at the ASTRO 2026 Annual Meeting isn't just about flashy presentations—it's looking to change how radiation oncology departments handle complex workflows. If you've ever delved into the maze of oncology billing, you know it's rife with opportunities for errors and inefficiencies. Skip one charge,...

Continue Reading
Melrose Fire Station Reaches Steel Topping Milestone

Updated Category News Views 5

Metal and Milestones: A New Era for Melrose Rolling into Melrose, Massachusetts, there's some serious action kicking off with the new Fire Engine 2 Station reaching a steel topping milestone. This phase isn't just about slapping on another beam; it's the crescendo of diligent teamwork from all the hands involved—from CTA Construction Managers to the clout of Ironworkers...

Continue Reading
Leo Cancer Care's Upright Radiotherapy Milestone

Updated Category News Views 4

Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...

Continue Reading

Top 5 Most Recently Viewed Articles

Transforming Security: The Fast Guard App Revolution

Updated Category News Views 109

Transforming Security with the Fast Guard App Fast Guard Service, a prominent name in licensed security guard services, has introduced a cutting-edge solution for the construction and property management sectors. This newly enhanced Fast Guard App empowers users to swiftly order and manage essential security services, including fire watch and armed or unarmed guards,...

Continue Reading
Weak Demand and Global Issues Impact China's Industries

Updated Category Economy Views 428

China's Industrial Profits Accelerate in June China's industrial gains in June increased more quickly, a reflection of good economic trends despite underlying problems. Official figures revealed a 3.6% year-on-year rise in profits, against a 0.7% increase in May. Strong industry output, according to the National Bureau of Statistics (NBS), helped to explain this increase....

Continue Reading
CyberArk Marks a Decade of Growth and Innovation Since IPO

Updated Category News Views 222

CyberArk Celebrates a Decade Since Its IPO In a significant milestone, CyberArk, a leader in identity security, marks ten years since its Initial Public Offering (IPO) on the NASDAQ. This anniversary serves as a moment for reflection and highlights essential achievements throughout the company's growth. Ringing the NASDAQ Bell to Honor Their Journey On the day of the...

Continue Reading
Projected Growth of the Biosurgery Market to $21.59 Billion

Updated Category News Views 145

Biosurgery Market Overview The global biosurgery market, currently valued at approximately US$14.96 billion, is expected to grow to a remarkable US$21.59 billion by a specified target year. This substantial growth, projected at an impressive CAGR of 6.4%, is fueled primarily by the urgent need for effective management of blood loss during surgical procedures and the rise...

Continue Reading
MIND Technology, Inc. Reports Growth Amidst Market Challenges

Updated Category News Views 188

Overview of MIND Technology's Recent Performance MIND Technology, Inc. (NASDAQ: MIND) has recently unveiled its financial outcomes for the third quarter of fiscal 2026. The company achieved revenues amounting to approximately $9.7 million during this period. Comparative Revenue Analysis This figure reflects a notable decrease from the $13.6 million realized in the prior...

Continue Reading